Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
are you still there Joe??
Whoa, something happening, up 9900% volume 853k what is up??
Hey Joe, we are down to nothing today despite some volume, back at 6 digits, .000001
Ended at 13 mil need to get out of expert market and get that reverse merger they have been promising, i guess we need some miracles!
another 5 mil right out of the gate this morning, ???
The SEC’s amendments to Rule 15c2-11 go into effect on September 28, 2021 and will effectively eliminate public broker-dealer quoting in securities of issuers that do not make current information publicly available. Giving effect to the SEC’s stated goals of encouraging public company disclosure, OTC Markets Group will use its Expert Market SM as a venue for broker-dealers to publish unsolicited quotes representing customer limit orders in “No Information” securities.
What is the Expert Market?
OTC Markets Group currently operates the Expert Market as a distinct market tier for a small number of companies. However, on September 28th this market tier will expand to include a broader range of securities. Following the upcoming changes to Rule 15c2-11, companies that do not make current information publicly available under the rule will shift to the Expert Market.
Quotes in the Expert Market will be “Unsolicited Only.” This means broker-dealers may use the Expert Market to meet their Best Execution responsibilities under FINRA Rules and publish unsolicited quotes representing Limit Orders from retail and institutional investors who are not affiliates or insiders of the company.
Who can access the Expert Market?
Quotations in Expert Market securities are restricted from public viewing. Only broker-dealers and professional or sophisticated investors are permitted to view quotations in Expert Market securities.
Despite the restrictions on who can view quotations, the Expert Market does not impose restrictions on who can trade securities. Rule 15c2-11 governs a broker’s ability to submit, publish or distribute quotations (i.e. bids and offers) in OTC securities. The Rule does not apply to the underlying transactions or the ability of an investor to buy or sell a security.
Contact your broker for information concerning restrictions or qualifications for accessing Expert Market securities.
Why is the Expert Market Important?
The Expert Market offers a regulated trading venue where broker-dealers can satisfy their best-execution obligations. It offers insight into activity that would otherwise be hidden in the opaque Grey Market.
How is Expert Market different from the Grey Market?
The Grey Market is an opaque market where broker-dealers are not willing or able to publicly quote OTC securities given the lack of investor interest, company information or regulatory compliance.
Unlike the Grey Market – where this is no public quote at all – the Expert Market provides additional price transparency, as it allows for unsolicited quoting.
How are Companies affected by these Changes?
The answer to this depends on the market on which your securities trade. In order to be quoted by broker-dealers on the Pink Market, a company must provide current public disclosure on an ongoing basis. This may include disclosure provided via the SEC’s EDGAR filing system, through a non-U.S. stock exchange or regulator, or to OTC Markets Group directly via our OTCIQ platform. Companies that do not take the necessary steps to make current disclosure available pursuant to the Pink Current or Pink Limited Guidelines may migrate to the Expert Market. Visit the Information for Pink Companies section of our website for further details.
What are the Key Dates for the Implementation of Rule 15c2-11?
We have asked companies to provide the required disclosure to OTC Markets by June 30th. This request was to ensure that our Issuer Compliance Team had sufficient time to confirm the availability of current information and update market status for a company’s securities prior to the rule’s compliance date on September 28th. We continue to process disclosure requests received after June 30th, however we may not be able to process all such applications prior to September 28th.
Under new Rule 15c2-11, Securities that do not meet the Rule’s current public disclosure requirements will be removed from Pink as of the September deadline.
Hi Joe up to 20 mil now, what is up??
Happy New Year Joe B, we are back to 4 digits, .0001
I did have TCEL several years ago and sold it at .00001 and sure enough a year later they did a reverse merger and it went to 3 cents, I always have bad timing.
No idea, I guess I have to make my own pizza for dinner tonight! I have never had a stock go this low, Oh well, I have seen some strange things happen, we cannot sell so might as well forget about this one for now.
Hey Joe, do you see where this is trading at .000001 today, cannot get much lower, 1M shares cost $1 today, pretty sad.
Last week some broker bought shares at .0003, later in the day it went back to .0001, it needs to get out of expert market for something to happen
From what I read, broker and dealers can still buy
Hey Joe, today there is 20mil
Thanks Joe, do you think this stock is going to bounce back??
Hi Joe, my online trading site says the volume today is 104m, how do we find out the pps today?
Here we go, news coming
6's up reverse merger?
5's almost gone
.0005's up volume up someone knows something!
see report UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 5, 2023 (May 1, 2023)
PROPANC BIOPHARMA, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-54878 33-0662986
(State or other jurisdiction
of Incorporation) (Commission
File Number) (IRS Employer
Identification Number)
302, 6 Butler Street
Camberwell, VIC, 3124 Australia
(Address of registrant’s principal executive office) (Zip code)
+61-03-9882-0780
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
? Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
? Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
? Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
? Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
N/A N/A N/A
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Item 3.03 Material Modification to Rights of Security Holders.
To the extent required by Item 3.03 of this Current Report on Form 8-K (this “Report”), the information contained in Item 5.03 of this Report is incorporated herein by reference.
Item 5.03 Amendments to Articles of Incorporation or Bylaws.
On May 1, 2023, Propanc Biopharma, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to its certificate of incorporation, as amended (the “Certificate of Incorporation”), to effect a one-for-one thousand reverse stock split (the “Reverse Stock Split”) of its outstanding shares of common stock, par value $0.001 per share (the “Common Stock”), effective as of May 1, 2023. In connection with the Reverse Stock Split, the Company submitted an issuer company-related action notification form to the Financial Industry Regulatory Authority, Inc. (“FINRA”) notifying FINRA of the Reverse Stock Split. The processing of the effects of the Reverse Stock Split by FINRA on the reported price of the Common Stock on the Pink® Open Market operated by the OTC Markets Group Inc. will occur at the time that the Reverse Stock Split is announced by FINRA on its over-the-counter daily list, which has not occurred as of the date of this Report.
As a result of the Reverse Stock Split, the Common Stock has been assigned a new CUSIP number (74346N602). The Reverse Stock Split does not affect the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, or the par value of the Common Stock, which shall remain as set forth pursuant to the Certificate of Incorporation. No fractional shares of Common Stock will be issued in connection with the Reverse Stock Split, all of which were rounded up to the nearest whole number. The Company’s outstanding warrants and equity awards will be adjusted as a result of the Reverse Stock Split, as required by the terms of such warrants and equity awards.
Securities Transfer Corporation, the Company’s transfer agent, will send instructions to stockholders of record who hold stock certificates regarding the exchange of any Common Stock certificates in connection with the Reverse Stock Split. Stockholders who hold their shares of Common Stock in book-entry form or in brokerage accounts or “street name” are not required to take any action to effect the exchange of their shares of Common Stock following the Reverse Stock Split.
The foregoing summary of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
Forward-Looking Statements
This Report contains, and may implicate, forward-looking statements regarding the Company, and include cautionary statements identifying important factors that could cause actual results to differ materially from those anticipated. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activities, or future events or conditions. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by its management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in documents that the Company files from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this Report, except as required by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit No. Description
3.1* Certificate of Amendment to Certificate of Incorporation of the Company
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
* Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 5, 2023 PROPANC BIOPHARMA, INC.
By: /s/ James Nathanielsz
Name: James Nathanielsz
Title: Chief Executive Officer and Chief Financial Officer
go to this link ir,propanc,com/all-sec-filing
I saw on twitter this morning that ppcb has announced on May 1 2023 a 1 for 1000 reverse stock split
ir,propanc,com/all-sec-filing I found this on twitter this morning, ppcb announced a 1 for 1000 reverse stock split on May 1 2023
I just sold my 500000 shares yesterday I paid .007 per share sold at
0018
if the pps is .0001 before the reverse split, then the pps after the r/s will be .15? Then after the r/s it will go back to .0001
I sold all of my shared right after the conference call, your million shares will be worth less than a dollar by the end of March
I just watched the cc, the reverse split is still in place, there is no buyer in place, all fluff no substance,
Thank you!
So, I guess no major news was dropped on the conference call?
I hope your right, I am keeping my shares
After the reverse split, the price of this stock will be approximately $5 per share. The price will quickly drop below $1per share so any hope of uplisting will vanish right away unless there is some earth shattering news that comes out instead of all the recent fluff and waste of time emerging growth conferences. I have held this stock for over a year now and have 500k shares which will soon become 333 shares. So, unless Dr. Koos have some significant news coming up, the R/S will be worthless.
What did the CEO say?
5 months ago they said they were going to change the company name and ticker symbol
NEW YORK, Oct. 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nexus Energy Services, Inc. (OTC Pink: IBGR) (“Nexus Energy Services, Inc. Doing Business as Applicate or the "Company”) has submitted its application to FINRA to change the company name and ticker symbol. Upon acceptance of the application, Nexus Energy Services, Inc. will be known as Applicate, Inc.
I am on your side, I am long, been holding for over a year now, we need answers and news asap, getting tired of their worthless tweets.
Good news the phone mumber is working again on the Applicate website
NEW TWEET
Hey Roof, yes thank God they gave us something
Thanks David, what are your thoughs?
He did not specify a date.